Truist Securities Downgrades Bausch Health Companies to Hold
Truist Securities analyst Gregory Fraser downgrades Bausch Health Companies (NYSE:BHC) from Buy to Hold.
Teladoc Health’s Revised Outlook ‘Implies More Downside’ According To This Analyst
Needham downgraded Teladoc Health Inc (NYSE:TDOC) to Hold following the company’s revised FY22 outlook, which now assumes the low end of…
Why Bausch Health’s Market Cap Was Chopped In Half Thursday: ‘A Near Worst-Case Scenario’
Shares of global health company Bausch Health Companies Inc (NYSE: BHC) are plunging Thursday after a Delaware federal judge issued an oral order on patents related to the company's Xifaxan drug.
Goldman Sachs Downgrades Align Tech to Sell, Lowers Price Target to $250
Goldman Sachs analyst Nathan Rice downgrades Align Tech (NASDAQ:ALGN) from Buy to Sell and lowers the price target from $380 to $250.
Macquarie Downgrades News to Neutral, Lowers Price Target to $21.1
Macquarie analyst Darren Leung downgrades News (NASDAQ:NWSA) from Outperform to Neutral and lowers the price target from $22.3 to $21.1.
Goldman Sachs Downgrades Teladoc Health to Neutral, Lowers Price Target to $36
Goldman Sachs analyst Cindy Motz downgrades Teladoc Health (NYSE:TDOC) from Buy to Neutral and lowers the price target from $55 to $36.
Guggenheim Downgrades F45 Training Holdings to Neutral
Guggenheim analyst John Heinbockel downgrades F45 Training Holdings (NYSE:FXLV) from Buy to Neutral.
Wedbush Downgrades Pegasystems to Neutral
Wedbush analyst Daniel Ives downgrades Pegasystems (NASDAQ:PEGA) from Outperform to Neutral.
JP Morgan Downgrades Cognizant Tech Solns to Neutral, Lowers Price Target to $77
JP Morgan analyst Tien-Tsin Huang downgrades Cognizant Tech Solns (NASDAQ:CTSH) from Overweight to Neutral and lowers the price target from $82 to $77.
Piper Sandler Downgrades Shopify to Neutral, Lowers Price Target to $32
Piper Sandler analyst Michael Olson downgrades Shopify (NYSE:SHOP) from Overweight to Neutral and lowers the price target from $38 to $32.